HCWB
HCW Biologics Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.51
−14.63%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- -$1.08
- Revenue estimate
- $119.0K
Latest reported
- Last report date
- Aug 14, 2026
- EPS actual
- -$12
- EPS estimate
- -$1.98
- Revenue actual
- $135.6K
- Revenue estimate
- $135.6K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 2
- EPS misses (12Q)
- 8
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -185.4%
- Revenue beats (12Q)
- 1
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 14, 2026 | -$1.98 | -$12 | Miss -484.85% | $135.6K |
| May 14, 2026 | -$0.44 | $0.37 | Beat 184.09% | $6.5M |
| Mar 31, 2026 | -$0.84 | -$2.63 | Miss -213.10% | — |
| Nov 14, 2025 | $1.58 | -$2.02 | Miss -227.85% | — |
| Aug 18, 2025 | $1.80 | -$6.79 | Miss -477.22% | $6.5K |
| May 15, 2025 | — | -$0.05 | — | $5.1K |
| Mar 28, 2025 | $3.60 | -$3.20 | Miss -188.89% | $394.8K |
| Nov 14, 2024 | -$5.20 | -$4.00 | Beat 23.08% | $426.4K |
| Aug 14, 2024 | -$7.20 | -$16 | Miss -122.22% | $618.9K |
| May 15, 2024 | — | -$8.00 | — | $1.1M |
| Nov 14, 2023 | -$0.13 | -$5.60 | Miss -4207.69% | $853.1K |
| Aug 11, 2023 | -$0.15 | -$4.80 | Miss -3100.00% | $622.8K |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026